Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • AI start-up fund: R25mn boost from Ngcaba for R100mn plan
    • James Bond’s Most Divisive Movie Is Officially Finding New Streaming Success
    • Bitcoin Recovers to $60,000 but Demand Stays Away: ¥92 Billion ETF Outflows and Weak US Buying Pressure Point to What a Bottom Would Require
    • A $300,000 REIT Portfolio Could Save Thousands in Taxes Inside a Roth IRA
    • CoreWeave co-founder buys $30 million in company bonds as debt trades at 81 cents per dollar
    • Egypt, Greece see significant opportunities for investment, trade: Finance minister – Dailynewsegypt
    • Prime Video Could Officially Give James Bond the ‘Young Sherlock’ Treatment
    • Eat, Sip, Shop: Seasoned chef serving up fresh, distinctive dishes at new Berks bistro | Eat, Sip, Shop
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»Mutual Funds»This SBI fund beat all its active peers with 20%+ SIP returns across 3, 5, and 10 years – Mutual Funds News
    Mutual Funds

    This SBI fund beat all its active peers with 20%+ SIP returns across 3, 5, and 10 years – Mutual Funds News

    August 20, 2026


    What if one mutual fund had managed to deliver more than 20% returns on SIP investments across three, five, and 10 years? SBI Healthcare Opportunities Fund has done exactly that.

    The fund has delivered 22.58% XIRR in three years, 24.04% in five years, and 20.97% in 10 years, making it the only active healthcare/pharma fund to cross the 20% mark across all three periods, according to Value Research data.

    Its strong performance is not limited to its sector peers. We analysed 36 active SBI Mutual Fund schemes across categories and found SBI Healthcare Opportunities Fund to be the best SBI fund for SIP returns across three, five and 10 years.

    The fund has also remained among SBI’s top performers for lump-sum investments. It tops the three-year chart with a 24.60% CAGR, ranks third over five years with 18.84%, and is among the top 10 SBI funds over 10 years with a 15.10% CAGR.

    But there is an important catch: this is a sectoral fund, with most of its money invested in healthcare. So, while the returns look impressive, investors also need to understand the risks before considering it.

    SBI Healthcare Opportunities Fund Performance

    The SBI Healthcare Opportunities Fund – direct plan has delivered strong long-term lump-sum returns, outperforming its benchmark across 3, 5 and 10-year time frames. 

    SIP performance

    Monthly SIP amount Investment duration Returns in % SIP would have grown to
    Rs 10,000 3 years 22.58 Rs 5 lakh approx
    Rs 10,000 5 years 24.04 Rs 10.88 lakh approx
    Rs 10,000 10 years 20.97 Rs 36.28 lakh approx

    Lump-sum performance

    The SBI Healthcare Opportunities Fund – Direct Plan has delivered strong returns across most time periods, outperforming its benchmark, the BSE Healthcare TRI, as well as its sectoral pharma category. The fund has generated a 23.90% return year-to-date (YTD), compared with 16.54% for the benchmark and 18.01% for the category. 

    The fund has continued to outperform the category and benchmark over the shorter term. In comparison to the benchmark’s 17.66% and the category’s 19.40%, it produced 23.65% in six months. Additionally noteworthy is the fund’s longer-term performance. SBI Healthcare Opportunities Fund outperformed the category at 16.30% and the benchmark at 14.67% over the course of a year, delivering 20.39%. 

    Fund name 3-Year Returns In % 5-Year Returns In % 10-Year Returns In %
    SBI Healthcare Opportunities Dir 24.60 18.84 15.10
    BSE Healthcare TRI 22.91 14.86 12.81
    Equity: Sectoral-Pharma 22.92 15.83 15.43

    Source: Value Research as of 19th August 2026

    SBI Healthcare Opportunities Fund performance vs other pharma funds

    Funds 3-Year SIP Returns In % 5-Year SIP Returns In % 10-Year SIP Returns In %
    SBI Healthcare Opportunities Dir 22.58 24.04 20.97
    UTI Healthcare Dir 21.38 22.46 19.83
    Mirae Asset Healthcare Dir 20.49 21.27 –
    ABSL Pharma & Healthcare Dir 19.02 20.56 –
    LIC MF Healthcare Dir 18.86 19.14 –
    DSP Healthcare Dir 18.54 20.75 –
    Quant Healthcare Dir 17.68 – –
    ICICI Pru Nifty Pharma Index Dir 17.50 – –
    ICICI Pru Pharma Healthcare and Diagnostics Dir 16.83 21.07 –
    ITI Pharma and Healthcare Dir 15.80 – –
    Tata India Pharma & Healthcare Dir 15.68 19.08 19.15
    Nippon India Pharma Dir 14.83 18.22 19.09

    Source: Value Research as of 19th August 2026

    Over the past three to five years, India’s post-COVID health expenditures, US FDA approvals for India to supply generic medicines, China+1 API manufacturing shift, rupee depreciation, strong company earnings, Biopharma SHAKTI initiative, persistent Production Linked Incentive (PLI) funding, strategic customs duty waivers on essential medicines, robust budget allocation for the pharma industry, and much more have all contributed to the rise in pharma and healthcare mutual funds. 

    About SBI Healthcare Opportunities Fund

    This sectoral pharma fund was launched by SBI Mutual Fund on January 01, 2013, which means that the fund has completed 13 years of existence. 

    Tanmaya Desai is the current fund manager of SBI Healthcare Opportunities Fund and has been managing the fund since June 2011. 

    The fund’s direct plan has an expense ratio of 0.75%, whereas the regular plan has a higher expense ratio of 1.59%. The fund’s AUM as of 31 Jul 2026 was Rs 5405.77Cr. 

    The fund makes at least 80% of its investments in equity and equity-related securities in the healthcare industry and the remaining 20% in debt or money market securities, as well as shares of companies outside the healthcare industry.

    The SBI Healthcare Opportunities Fund carries a relatively high risk profile, primarily because it is a sector-focused equity fund with significant exposure to healthcare and pharmaceutical companies. Its standard deviation is 14.36%, beta is 0.84, and Sharpe ratio is 1.16. 

    Top stock-wise holdings

    Top 10 companies Net% To AUM
    Sun Pharmaceutical Industries 12.72
    Divi’S Laboratories 7.46
    Acutaas Chemicals 5.17
    Cipla 5.07
    Apollo Hospitals Enterprise 4.98
    Torrent Pharmaceuticals 4.74
    Max Healthcare Institute 4.58
    Laurus Labs 4.04
    Aurobindo Pharma 3.86
    Aster Dm Quality Care 3.65

    Source: Fund factsheet as of 31/07/2026

    Top sector-wise allocation

    Sectors Net% To AUM
    Healthcare 93.81
    Chemicals 4.5
    Cash and cash equivalents (CCE) 1.64
    Sovereign 0.05

    Key takeaway

    Companies involved in pharmaceuticals, hospitals, medical equipment, healthcare service providers, and biotechnology make up the healthcare space. 

    Because the SBI Healthcare Opportunities Fund comes from the pharmaceutical industry, it poses a much higher risk than other diversified funds. 

    Although the scheme has consistently beaten its benchmark, investors should not expect the same returns in the future because mutual funds are susceptible to market risk, and prior performance should not be expected in the future. 

    The SBI Healthcare Opportunities Fund appears to be a robust healthcare-sector fund, but only in terms of returns over the next three, five, and ten years. You shouldn’t choose the fund just because of the past returns. The SBI Healthcare Opportunities Fund is a good option for investors who already have diversified funds in their portfolio, but new investors should avoid it due to its high concentration risk when compared to other diversified funds like flexi-cap or multi-cap, large and mid-cap funds, or multi-asset and hybrid categories. 

    Investors who have long-term financial goals of 5 to 7 years and can tolerate sector-specific volatility can consider investing in SBI Healthcare Opportunities Fund, and those having low risk tolerance and looking for guaranteed/steady returns should avoid it, 

    Sector outlook, consistency of outperformance, portfolio concentration, fund manager’s track record, expense ratio, downside risk, valuation of underlying stocks, and overlap with existing mutual funds are important considerations when choosing a fund. 

    Disclaimer: This article is for informational purposes only and should not be construed as investment, financial, tax, or legal advice. Any illustrations, examples, or return projections used in this article are for explanatory purposes only and do not guarantee actual investment outcomes. The views and opinions expressed by experts quoted in this article are their own and should not be considered investment recommendations. Readers should consult a qualified professional before making any financial decisions. 

    Every financial journey has a turning point. What’s yours?

    Financial Express is launching a new series highlighting real experiences with money, investments, and the taxman. Did a sudden tax rule catch you off guard? Did a piece of financial advice change your life? Your story could provide invaluable, practical lessons for thousands of fellow taxpayers. Share your experience with us. We respect your privacy: no stories will be featured without a direct conversation and your full consent. Thank you.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    A $300,000 REIT Portfolio Could Save Thousands in Taxes Inside a Roth IRA

    November 21, 2026

    For Beginners Investing in Mutual Funds That Are Unavailable on New York or London Holidays: Even If December 25th (Friday) Is Your Scheduled Investment Date, You Cannot Purchase on That Day

    November 21, 2026

    Retired couple’s Medicare costs triple after move to a Minnesota county without Medicare Advantage plan options in 2027

    November 21, 2026
    Leave A Reply Cancel Reply

    Top Posts

    James Bond’s Most Divisive Movie Is Officially Finding New Streaming Success

    November 21, 2026

    AI start-up fund: R25mn boost from Ngcaba for R100mn plan

    November 21, 2026

    Christian Candy: Inside His Billion-Pound Property Empire, Net Worth, Wife and Luxury Lifestyle

    November 20, 2026

    Egypt, Greece see significant opportunities for investment, trade: Finance minister – Dailynewsegypt

    November 21, 2026
    Don't Miss
    Funds

    AI start-up fund: R25mn boost from Ngcaba for R100mn plan

    November 21, 2026

    A proposed R100mn ($5.7mn) AI start-up fund for South Africa has a first backer: investor…

    James Bond’s Most Divisive Movie Is Officially Finding New Streaming Success

    November 21, 2026

    Bitcoin Recovers to $60,000 but Demand Stays Away: ¥92 Billion ETF Outflows and Weak US Buying Pressure Point to What a Bottom Would Require

    November 21, 2026

    A $300,000 REIT Portfolio Could Save Thousands in Taxes Inside a Roth IRA

    November 21, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    The Ultimate 2025 Guide to Index Tracker Funds in the UK

    May 29, 2025

    BSEC okays draft prospectuses of three closed-end mutual funds

    January 13, 2026

    PhonePe Wealth launches mutual fund analysis tool CRISP

    March 20, 2025
    Our Picks

    AI start-up fund: R25mn boost from Ngcaba for R100mn plan

    November 21, 2026

    James Bond’s Most Divisive Movie Is Officially Finding New Streaming Success

    November 21, 2026

    Bitcoin Recovers to $60,000 but Demand Stays Away: ¥92 Billion ETF Outflows and Weak US Buying Pressure Point to What a Bottom Would Require

    November 21, 2026
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    💵 Libra responds after Flamengo takes legal action and ‘freezes’ funds

    September 26, 2025

    🇮🇸 CPP Investments and Equinix complete atNorth acquisition to support growth of leading Nordic data center platform

    September 1, 2026
    © 2026 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.